Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marla Dubinsky

Showing results (121-130 of 151) with videos related to

Pageof 16
Sort By:
Gastroenterology|September 25, 2020
Predicting Outcomes in Pediatric Ulcerative Colitis for Management Optimization: Systematic Review and Consensus Statements From the Pediatric Inflammatory Bowel Disease-Ahead ProgramEsther Orlanski-Meyer, Martine Aardoom, Amanda Ricciuto, et al.
Gastroenterology|September 26, 2020
Predicting Outcomes in Pediatric Crohn's Disease for Management Optimization: Systematic Review and Consensus Statements From the Pediatric Inflammatory Bowel Disease-Ahead ProgramAmanda Ricciuto, Martine Aardoom, Esther Orlanski-Meyer, et al.
Cellular and Molecular Gastroenterology and Hepatology|April 4, 2021
Deep Analysis of the Peripheral Immune System in IBD Reveals New Insight in Disease Subtyping and Response to Monotherapy or Combination TherapyRoman Kosoy, Seunghee Kim-Schulze, Adeeb Rahman, et al.
Gut|May 1, 2019
Infants born to mothers with IBD present with altered gut microbiome that transfers abnormalities of the adaptive immune system to germ-free miceJoana Torres, Jianzhong Hu, Akihiro Seki, et al.
The New England Journal of Medicine|July 17, 2024
Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's DiseaseLaurent Peyrin-Biroulet, J Casey Chapman, Jean-Frederic Colombel, et al.
Journal of Crohn'S & Colitis|October 21, 2023
Analysis of Clinical Trial Screen Failures in Inflammatory Bowel Diseases [IBD]: Real World Results from the International Organization for the study of IBDSophie Vieujean, James O Lindsay, Ferdinando D'Amico, et al.
Nature Reviews. Gastroenterology & Hepatology|October 3, 2023
Precision medicine in monogenic inflammatory bowel disease: proposed mIBD REPORT standardsHolm H Uhlig, Claire Booth, Judy Cho, et al.
BMJ Open Gastroenterology|February 20, 2026
Evaluating treatment to a target of transmural healing in patients with moderately to severely active Crohn's disease: rationale, design and protocol for the randomised controlled VECTORS trialVipul Jairath, Sudheer K Vuyyuru, Guangyong Zou, et al.
Gastroenterology|December 11, 2020
Longitudinal Changes in Fecal Calprotectin Levels Among Pregnant Women With and Without Inflammatory Bowel Disease and Their BabiesEun Soo Kim, Leonid Tarassishin, Caroline Eisele, et al.
Inflammatory Bowel Diseases|January 16, 2021
Association of Baseline Luminal Narrowing With Ileal Microbial Shifts and Gene Expression Programs and Subsequent Transmural Healing in Pediatric Crohn DiseaseAllison D Ta, Nicholas J Ollberding, Rebekah Karns, et al.
Pageof 16

Showing results (121-130 of 151) with videos related to

Sort By:
Pageof 16
Gastroenterology|September 25, 2020
Predicting Outcomes in Pediatric Ulcerative Colitis for Management Optimization: Systematic Review and Consensus Statements From the Pediatric Inflammatory Bowel Disease-Ahead ProgramEsther Orlanski-Meyer, Martine Aardoom, Amanda Ricciuto, et al.
Gastroenterology|September 26, 2020
Predicting Outcomes in Pediatric Crohn's Disease for Management Optimization: Systematic Review and Consensus Statements From the Pediatric Inflammatory Bowel Disease-Ahead ProgramAmanda Ricciuto, Martine Aardoom, Esther Orlanski-Meyer, et al.
Cellular and Molecular Gastroenterology and Hepatology|April 4, 2021
Deep Analysis of the Peripheral Immune System in IBD Reveals New Insight in Disease Subtyping and Response to Monotherapy or Combination TherapyRoman Kosoy, Seunghee Kim-Schulze, Adeeb Rahman, et al.
Gut|May 1, 2019
Infants born to mothers with IBD present with altered gut microbiome that transfers abnormalities of the adaptive immune system to germ-free miceJoana Torres, Jianzhong Hu, Akihiro Seki, et al.
The New England Journal of Medicine|July 17, 2024
Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's DiseaseLaurent Peyrin-Biroulet, J Casey Chapman, Jean-Frederic Colombel, et al.
Journal of Crohn'S & Colitis|October 21, 2023
Analysis of Clinical Trial Screen Failures in Inflammatory Bowel Diseases [IBD]: Real World Results from the International Organization for the study of IBDSophie Vieujean, James O Lindsay, Ferdinando D'Amico, et al.
Nature Reviews. Gastroenterology & Hepatology|October 3, 2023
Precision medicine in monogenic inflammatory bowel disease: proposed mIBD REPORT standardsHolm H Uhlig, Claire Booth, Judy Cho, et al.
BMJ Open Gastroenterology|February 20, 2026
Evaluating treatment to a target of transmural healing in patients with moderately to severely active Crohn's disease: rationale, design and protocol for the randomised controlled VECTORS trialVipul Jairath, Sudheer K Vuyyuru, Guangyong Zou, et al.
Gastroenterology|December 11, 2020
Longitudinal Changes in Fecal Calprotectin Levels Among Pregnant Women With and Without Inflammatory Bowel Disease and Their BabiesEun Soo Kim, Leonid Tarassishin, Caroline Eisele, et al.
Inflammatory Bowel Diseases|January 16, 2021
Association of Baseline Luminal Narrowing With Ileal Microbial Shifts and Gene Expression Programs and Subsequent Transmural Healing in Pediatric Crohn DiseaseAllison D Ta, Nicholas J Ollberding, Rebekah Karns, et al.
Pageof 16